Intrinsiqq
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd.

CMMB

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$622M
EPS$0.02
P/E67.78
P/FCF-55.91
EV/EBITDA-5.49
FCF Yield–
Div. Yield–
Net Debt/FCF0.7x
Chemomab Therapeutics Ltd. intrinsic value
52-Week Range
$1.00$2.83

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$9M

▲ +35.5% YoY

Op. Margin

–

ROIC

-675.55%

▼ -88.5pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$11M

▲ +27.6% YoY

Op. Cash Flow (TTM)

-$11M

▲ +27.7% YoY

Net Debt

-$8M

Net Cash Position

Cash & Equiv.

$8M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with CMMB

CompareIntrinsic value
LFVNLifeVantage Corporation
$4.15-15.13%68
JAZZJazz Pharmaceuticals plc
$230.26-2.62%58
AMPHAmphastar Pharmaceuticals Inc.
$28.25+0.50%64
PCYNProcyon Corporation
$0.18+0.00%20
RGBPRegen Biopharma Inc.
$0.00-50.00%25
ELTPElite Pharmaceuticals Inc.
$0.32+0.69%81
REGNRegeneron Pharmaceuticals, Inc.
$920.69-0.29%54
INVAInnoviva Inc.
$18.41+0.00%60

Chemomab Therapeutics (CMMB) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
67.78
Price to free cash flow -55.91.
Financials

Questions about Chemomab Therapeutics

Is Chemomab Therapeutics (CMMB) overvalued?

Chemomab Therapeutics trades at 67.78 times earnings. Intrinsiqq's fair value calculator has no opening value for CMMB, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.

Does Chemomab Therapeutics (CMMB) pay a dividend?

No. Chemomab Therapeutics (CMMB) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-K filed 23 Mar 2026 (period ending 31 Dec 2025), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in CMMB's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CMMB

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.